Farzin Beygui

13PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsCardiology (incl. cardiovascular diseases)Molecular targetsEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 04, 2025
Benefit-risk of colchicine and spironolactone in acute myocardial infarction: a prespecified generalised pairwise comparisons analysis of the CLEAR trial.

Marc-André d'Entremont, Sanjit S Jolly, Faisal Alharthi

|Aug 29, 2025
Combined plasma levels of A-type-natriuretic peptide and adrenomedullin are associated with appropriate anti-arrhythmia therapy in patients with an implantable cardioverter defibrillator but no prior device therapy.

Farzin Beygui, Vincent Roule, Estelle Gandjbakhch

|May 06, 2025
Role of sub-clinical inflammation and defective cholesterol efflux in myocardial infarction patients without standard modifiable risk factors.

Vincent Roule, Farzin Beygui, Maryse Guerin

|Sep 21, 2024
Safety and efficacy of apixaban versus warfarin in peritoneal dialysis patients with non-valvular atrial fibrillation: protocol for a prospective, randomised, open-label, blinded endpoint trial (APIDP2).

Maxence Ficheux, Laure Peyro-Saint-Paul, Dorothée Balayn

|Mar 04, 2024
Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial.

Eric Durand, Delphine Beziau-Gasnier, Morgane Michel

|Jan 12, 2024
Flecainide to prevent atrial arrhythmia after patent foramen ovale closure, Rationale and design of the randomized AFLOAT study.

Marie Hauguel-Moreau, Paul Guedeney, Claire Dauphin

Pageof 3

Frequent Collaborators

4 joint publications

Vincent Roule

3 joint publications

Johanne Silvain

3 joint publications

Gilles Montalescot

2 joint publications

Jean-Philippe Collet